| 发明名称 |
Sustained release pharmaceutical composition containing tamsulosin comprises specific dissolution profile ensuring high activity without side-effects, useful for treating urinary disorders such as benign prostate hyperplasia |
| 摘要 |
<p>A sustained release pharmaceutical composition (A) comprising tamsulosin (I) (or its salt) and a carrier (II) such that in Japanese Pharmacopoeia dissolution test 2 (paddle method; 200 rpm) the degree of release of (I) 7 hours after the start of dissolution is 20-85%, is new. ACTIVITY : Cytostatic; Uropathic. No biological data given. MECHANISM OF ACTION : alpha -Adrenergic receptor blocker. No biological data given.</p> |
| 申请公布号 |
DE202004009563(U1) |
申请公布日期 |
2004.11.11 |
| 申请号 |
DE20042009563U |
申请日期 |
2004.06.09 |
| 申请人 |
YAMANOUCHI PHARMACEUTICAL CO., LTD. |
发明人 |
|
| 分类号 |
A61K9/00;A61K9/20;A61K31/18;(IPC1-7):A61K31/18 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
